The Use of a Memokath Prostatic Stent for Obstructive Voiding Symptoms after Brachytherapy | Zendy

G. W. de Graaf | Zendy; Pascal E.F. Stijns | Zendy; Wout Scheepens | Zendy; R. Jeroen A. van Moorselaar | Zendy; Ad J.M. Hendrikx | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Use of a Memokath Prostatic Stent for Obstructive Voiding Symptoms after Brachytherapy

Author(s) -

G. W. de Graaf,

Pascal E.F. Stijns,

Wout Scheepens,

R. Jeroen A. van Moorselaar,

Ad J.M. Hendrikx

Publication year - 2013

Publication title -

current urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.476

H-Index - 13

eISSN - 1661-7657

pISSN - 1661-7649

DOI - 10.1159/000343547

Subject(s) - medicine , brachytherapy , stent , urology , prostate , international prostate symptom score , catheter , surgery , urination , prostate brachytherapy , lower urinary tract symptoms , radiation therapy , urinary system , cancer

Brachytherapy may be complicated by serious obstructive voiding symptoms (OVS). Only conservative treatment options are available in the first 6 months after brachytherapy. We evaluated safety, efficacy and patient tolerance of the Memokath prostatic stent (MPS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research